We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$98.2M
Cap. Flow %
95.28%
Top 10 Hldgs %
26.91%
Holding
111
New
111
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 16.78%
3 Energy 13.93%
4 Financials 12.08%
5 Miscellaneous 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WLY icon
76
John Wiley & Sons Class A
WLY
$2.52B
$425K 0.41%
+7,700
New +$389K
2013 Q4
0 quarters
OESX icon
77
Orion Energy Systems
OESX
$106M
$422K 0.41%
+6,213
New +$329K
2013 Q4
0 quarters
NVS icon
78
Novartis
NVS
$273B
$418K 0.41%
+5,803
New +$403K
2013 Q4
0 quarters
FAX icon
79
abrdn Asia-Pacific Income Fund
FAX
$531M
$406K 0.39%
+11,733
New +$430K
2013 Q4
0 quarters
BTH
80
DELISTED
BLYTH,INC
BTH
$392K 0.38%
+36,005
New +$444K
2013 Q4
0 quarters
XOM icon
81
ExxonMobil
XOM
$695B
$378K 0.37%
+3,735
New +$345K
2013 Q4
0 quarters
SONY icon
82
Sony
SONY
$141B
$339K 0.33%
+98,000
New +$362K
2013 Q4
0 quarters
CVX icon
83
Chevron
CVX
$416B
$334K 0.32%
+2,674
New +$323K
2013 Q4
0 quarters
NOK icon
84
Nokia
NOK
$58B
$324K 0.31%
+40,000
New +$301K
2013 Q4
0 quarters
GILD icon
85
Gilead Sciences
GILD
$187B
$300K 0.29%
+4,000
New +$279K
2013 Q4
0 quarters
RLGT icon
86
Radiant Logistics
RLGT
$432M
$294K 0.29%
+109,750
New +$251K
2013 Q4
0 quarters
AAPL icon
87
Apple
AAPL
$4.91T
$274K 0.27%
+13,664
New +$258K
2013 Q4
0 quarters
KGC icon
88
Kinross Gold
KGC
$28.2B
$274K 0.27%
+62,515
New +$298K
2013 Q4
0 quarters
KYN icon
89
Kayne Anderson Energy Infrastructure Fund
KYN
$2.41B
$247K 0.24%
+6,206
New +$228K
2013 Q4
0 quarters
COP icon
90
ConocoPhillips
COP
$161B
$244K 0.24%
+3,452
New +$248K
2013 Q4
0 quarters
ABBV icon
91
AbbVie
ABBV
$489B
$203K 0.2%
+3,840
New +$189K
2013 Q4
0 quarters
NYV
92
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
$203K 0.2%
+15,000
New +$202K
2013 Q4
0 quarters
TTI icon
93
TETRA Technologies
TTI
$905M
$199K 0.19%
+16,100
New +$201K
2013 Q4
0 quarters
PER
94
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$188K 0.18%
+15,900
New +$216K
2013 Q4
0 quarters
IVAC icon
95
DELISTED
Intevac Inc
IVAC
$169K 0.16%
+22,750
New +$138K
2013 Q4
0 quarters
LTRX icon
96
Lantronix
LTRX
$321M
$162K 0.16%
+103,839
New +$158K
2013 Q4
0 quarters
DXYN icon
97
DELISTED
Dixie Group Inc
DXYN
$159K 0.15%
+12,050
New +$142K
2013 Q4
0 quarters
LPTH icon
98
Lightpath Technologies
LPTH
$681M
$157K 0.15%
+115,643
New +$158K
2013 Q4
0 quarters
STRP
99
DELISTED
Straight Path Communications Inc.
STRP
$138K 0.13%
+16,830
New +$110K
2013 Q4
0 quarters
DAEG
100
DELISTED
DAEGIS INC
DAEG
$126K 0.12%
+105,451
New +$102K
2013 Q4
0 quarters

Similar funds

Penbrook Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Penbrook Management, which disclosed 111 positions worth $103M. Its ten largest holdings account for 27% of the portfolio.

Its largest position is Novo Nordisk: 254,000 shares worth $4.69M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Healthcare and Energy.

  • Penbrook Management's largest Q4 2013 buy was Novo Nordisk: 254,000 shares worth $4.69M.
  • Penbrook Management's ten largest holdings make up 27% of its $103M portfolio in Q4 2013.
  • Penbrook Management disclosed 111 positions in Q4 2013, its first 13F filing on record.

Based on Penbrook Management's 13F filing for Q4 2013, filed 25 Mar 2014.